Pharmaceutical openbaar
[search 0]
Meer
Download the App!
show episodes
 
Artwork

1
Pharmaceutical Executive

Pharmaceutical Executive Podcast

Unsubscribe
Unsubscribe
Maandelijks+
 
The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and http://PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.
  continue reading
 
DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management
  continue reading
 
Welcome to the Biotech Bytes podcast, where we sit down with Biotech and Pharma IT leaders to learn what's working in our industry. Steven Swan is the CEO of The Swan Group LLC. He has 20 years of experience working with companies and individuals to make long-term matches. Focusing on Information technology within the Biotech and Pharmaceutical industries has allowed The Swan Group to become a valued partner to many companies. Staying in constant contact with the marketplace and its trends a ...
  continue reading
 
Loading …
show series
 
The rapid advancements in biotechnology are transforming the industry. Emerging technologies hold the promise of revolutionizing healthcare and enhancing our quality of life. In this episode, I sit down with Steven Bressler, a fractional CIO from Strategic Technology Management, Inc., to discuss the latest trends in biotechnology. We explore the po…
  continue reading
 
Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses: Top legal and regulatory concerns for investors considering when financing companies developing or marketing GLP-1 drugs How the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs What needs to be done…
  continue reading
 
As companies evolve, the structuring and management of data become critical for scalability and efficiency. Failure to prioritize this can hinder the adoption of advanced technologies like machine learning. Nathan McBride, Senior Vice President of IT at Xilio Therapeutics, Inc., joins me today to explore the intricacies of effective data structurin…
  continue reading
 
Loading …

Korte handleiding